ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Doctor-Led Cosmeceutical Line ESHO to Launch in the US After UK Success

By: Get News
ESHO highlights clinical cosmeceutical products that offer targeted results.

ESHO, the world's first doctor-led, targeted lip cosmeceutical line, is all set to expand its reach and launch in the US following a highly successful run across the UK market.

With its unique approach that combines scientific research and targeted ingredients to cater to diverse lip concerns, ESHO has established itself as a game-changer in the cosmeceutical industry. It has garnered a reputation for delivering remarkable results and has become a go-to choice for consumers looking to achieve beautiful, healthy-looking lips.

Since its launch in 2021, ESHO has been breaking records, becoming the fastest-selling lip line in the UK QVC history – a product selling every 30 seconds. It has also won multiple awards and received significant recognition in the beauty industry from celebrities and influencers alike. Dua Lipa, Michelle Keegan, Tiara Willis, and James Welsh are just a few of the many personalities who love and swear by ESHO's results.

According to Dr. Tijion Esho, a.k.a. "The Lip Doctor," a renowned cosmetic doctor and founder of ESHO, the brand's success lies in its unique formulations and scientific approach to lip care. Each product is crafted with clinically proven ingredients and draws on Dr. Esho's medical expertise and cutting-edge research.

He says, "ESHO is the world's first full lip cosmeceutical line to give people in-clinic results within their own home."

From treating dryness and chapping to plumping and lip sculpting, ESHO's targeted lip cosmeceuticals are designed to provide in-clinic results within the comfort of one's own home. The ESHO line offers a more affordable, non-surgical alternative to expensive, invasive lip treatments.

Currently, the brand provides six lip products, each addressing a specific concern.

COAT helps heal and protect the lips; PAUSE keeps the lips youthful; SCULPT plumps and volumizes; and DRENCH intensely hydrates and soothes dry and chapped lips. The newest additions to the original line are SEAL, an overnight lip mask that nourishes and repairs, and RENEW, a gentle lip peel that removes dead skin cells, revealing smoother and softer lips.

ESHO has proven that delivering in-clinic, visible results through cosmeceutical products is possible, while its success in the UK demonstrates a strong demand for clinical science-backed lip solutions.

With its US launch on the horizon, it will be exciting to see how ESHO's unique approach to lip care and cosmeceuticals impacts the US beauty industry and beyond. It is also a step toward making doctor-led cosmeceutical products more accessible.

Find more information here: http://www.esho.co.uk/.

Media Contact
Company Name: ESHO
Contact Person: Emma Pearce
Email: Send Email
Country: United Kingdom
Website: http://www.esho.co.uk/



Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.